Budget Amount *help |
¥16,770,000 (Direct Cost: ¥12,900,000、Indirect Cost: ¥3,870,000)
Fiscal Year 2011: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2010: ¥7,020,000 (Direct Cost: ¥5,400,000、Indirect Cost: ¥1,620,000)
Fiscal Year 2009: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
|
Research Abstract |
In the present study, we demonstrated that transplantation of mouse induced pluripotent stem cells(iPSC) derived neural stem/progenitor cells(NS/PCs) promoted functional recovery after spinal cord injury(SCI) in mice. Furthermore, transplantation of human iPSC-NS/PC also promoted functional recovery after SCI in NOD/scid mice as well as common marmosets without any tumor formation as long as pre-evaluated''safe" human iPSC-NS/PCs were used as a cell source. Pre-evaluated'safe' human iPSC-NS/PCs s may be a promising cell source for transplantation therapy for patients with SCI.
|